Quote:

---

Had a number of options go zero as they expired with no value. Understood the risks and did fine on the ones that shot up in value. No longer doing options. CYDY has the same risk/reward ratio.

---

The risk in options is investor sentiment. You can have a company hit expected earnings but not beat it and the share price drops anyways. With Cytodyn the science is there. The risk is in ability to execute. With the team we have now the ability to execute is up a hundredfold. The one sticking point is the financials. There should enough money to finish the mssCRC trial and the Alzheimer's pilot study costs us nothing. With results from either the ability for Cytodyn to raise money is immensely improved.

So I would say the risk vs. options is less and the rewards can be vastly greater. It's just a matter of patience.